来源:瑞恩资本巨子生物(02367.HK),4月17日早间宣布,先旧后新配售3500万股,每股配售价66.65港元,募资23.33亿港元,募资净额22.94亿港元,拟用于核心业务的发展及生态圈布局,包括但不限于品牌推广、市场营销、品类扩展、海外业务及研发投入,以及补充流动资金及作一般企业用途。较昨日收市价73.65港元折让9.5%,配售股份占扩大后股本约3.27%。巨子生物,于2022年11月4日...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.